Cargando…

WCN23-0117 PAXLOVID ( NIRMATRELVIR/RITONAVIR ) AND CYCLOSPORIN IN A KIDNEY TRANSPLANT PATIENT WITH COVID-19 INFECTION

Detalles Bibliográficos
Autores principales: Then, R.F., Shahnaz Shah, F.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025675/
http://dx.doi.org/10.1016/j.ekir.2023.02.1024
_version_ 1784909388869271552
author Then, R.F.
Shahnaz Shah, F.K.
author_facet Then, R.F.
Shahnaz Shah, F.K.
author_sort Then, R.F.
collection PubMed
description
format Online
Article
Text
id pubmed-10025675
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-100256752023-03-21 WCN23-0117 PAXLOVID ( NIRMATRELVIR/RITONAVIR ) AND CYCLOSPORIN IN A KIDNEY TRANSPLANT PATIENT WITH COVID-19 INFECTION Then, R.F. Shahnaz Shah, F.K. Kidney Int Rep Covid-19 and KF (Kidney Failure) Published by Elsevier Inc. 2023-03 2023-03-20 /pmc/articles/PMC10025675/ http://dx.doi.org/10.1016/j.ekir.2023.02.1024 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Covid-19 and KF (Kidney Failure)
Then, R.F.
Shahnaz Shah, F.K.
WCN23-0117 PAXLOVID ( NIRMATRELVIR/RITONAVIR ) AND CYCLOSPORIN IN A KIDNEY TRANSPLANT PATIENT WITH COVID-19 INFECTION
title WCN23-0117 PAXLOVID ( NIRMATRELVIR/RITONAVIR ) AND CYCLOSPORIN IN A KIDNEY TRANSPLANT PATIENT WITH COVID-19 INFECTION
title_full WCN23-0117 PAXLOVID ( NIRMATRELVIR/RITONAVIR ) AND CYCLOSPORIN IN A KIDNEY TRANSPLANT PATIENT WITH COVID-19 INFECTION
title_fullStr WCN23-0117 PAXLOVID ( NIRMATRELVIR/RITONAVIR ) AND CYCLOSPORIN IN A KIDNEY TRANSPLANT PATIENT WITH COVID-19 INFECTION
title_full_unstemmed WCN23-0117 PAXLOVID ( NIRMATRELVIR/RITONAVIR ) AND CYCLOSPORIN IN A KIDNEY TRANSPLANT PATIENT WITH COVID-19 INFECTION
title_short WCN23-0117 PAXLOVID ( NIRMATRELVIR/RITONAVIR ) AND CYCLOSPORIN IN A KIDNEY TRANSPLANT PATIENT WITH COVID-19 INFECTION
title_sort wcn23-0117 paxlovid ( nirmatrelvir/ritonavir ) and cyclosporin in a kidney transplant patient with covid-19 infection
topic Covid-19 and KF (Kidney Failure)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025675/
http://dx.doi.org/10.1016/j.ekir.2023.02.1024
work_keys_str_mv AT thenrf wcn230117paxlovidnirmatrelvirritonavirandcyclosporininakidneytransplantpatientwithcovid19infection
AT shahnazshahfk wcn230117paxlovidnirmatrelvirritonavirandcyclosporininakidneytransplantpatientwithcovid19infection